Publication | Closed Access

An economic evaluation of a European cohort from a multinational trial of linezolid versus teicoplanin in serious Gram-positive bacterial infections: the importance of treatment setting in evaluating treatment effects

Health SciencesAntimicrobial StewardshipAntibioticsHealthcare-associated InfectionMicrobiologyInfection ControlEconomic EvaluationMedicineEuropean CohortClinical MicrobiologyAntimicrobial ResistanceEpidemiologyMultinational TrialDrug Resistance